https://dermfield.com/articles/rare-severe-gardner-diamond-syndrome-like-neutrophil-report-db76534e Derm Field en 2026-10-20T11:25:02.302Z Rare Severe Gardner-Diamond Syndrome-Like Neutrophil Report https://dermfield.com/articles/jaad-pilot-pits-intralesional-ala-pdt-against-topical-pdt-with-co2-laser-ee8b8853 Derm Field en 2026-10-20T11:25:02.302Z JAAD Pilot Pits Intralesional ALA-PDT Against Topical PDT With CO2 Laser https://dermfield.com/articles/glp-1-medicolegal-exposure-under-review-in-jaad-november-issue-72d44259 Derm Field en 2026-10-20T11:25:02.302Z GLP-1 medicolegal exposure under review in JAAD November issue https://dermfield.com/articles/jaad-paper-reconsiders-occipital-scalp-in-advanced-hair-loss-1ebafe61 Derm Field en 2026-10-20T11:20:02.381Z JAAD Paper Reconsiders Occipital Scalp in Advanced Hair Loss https://dermfield.com/articles/jaad-comment-sets-biopsy-geometry-rules-for-acral-lesions-776eac17 Derm Field en 2026-10-20T11:15:02.287Z JAAD Comment Sets Biopsy Geometry Rules for Acral Lesions https://dermfield.com/articles/jaad-psychodermatology-paper-covers-u-s-court-cases-from-19142025-ece49c13 Derm Field en 2026-10-20T11:15:02.287Z JAAD psychodermatology paper covers U.S. court cases from 1914–2025 https://dermfield.com/articles/jaad-study-asks-how-much-of-a-biologic-s-power-is-the-drug-itself-f478dd21 Derm Field en 2026-10-20T11:15:02.287Z JAAD Study Asks: How Much of a Biologic's Power Is the Drug Itself? https://dermfield.com/articles/jaad-publishes-multicenter-series-on-checkpoint-inhibitor-eosinophilic-fasciitis-632da05a Derm Field en 2026-10-20T11:15:02.287Z JAAD Publishes Multicenter Series on Checkpoint-Inhibitor Eosinophilic Fasciitis https://dermfield.com/articles/adjuvant-radiation-shows-no-survival-gain-in-low-risk-merkel-cell-carcinoma-d76ae01f Derm Field en 2026-10-20T11:15:02.287Z Adjuvant Radiation Shows No Survival Gain in Low-Risk Merkel Cell Carcinoma https://dermfield.com/articles/parallel-polarized-dermoscopy-under-study-for-acral-pattern-analysis-382380b7 Derm Field en 2026-10-20T11:15:02.287Z Parallel-Polarized Dermoscopy Under Study for Acral Pattern Analysis https://dermfield.com/articles/jaad-flags-emerging-sexually-transmissible-pathogens-beyond-classic-stis-e2c6e99f Derm Field en 2026-10-20T11:15:02.287Z JAAD flags emerging sexually transmissible pathogens beyond classic STIs https://dermfield.com/articles/jaad-calls-for-transparent-reporting-as-ai-enters-evidence-synthesis-a78a503c Derm Field en 2026-10-20T11:15:02.287Z JAAD Calls for Transparent Reporting as AI Enters Evidence Synthesis https://dermfield.com/articles/rosacea-interventions-compared-across-phenotype-relevant-outcomes-1abec132 Derm Field en 2026-10-20T11:15:02.287Z Rosacea interventions compared across phenotype-relevant outcomes https://dermfield.com/articles/jaad-study-asks-can-intralesional-5-fu-intervals-stretch-in-low-risk-scc-0e80f91b Derm Field en 2026-10-20T11:15:02.287Z JAAD Study Asks: Can Intralesional 5-FU Intervals Stretch in Low-Risk SCC? https://dermfield.com/articles/jaad-ethics-review-targets-coordinated-interview-releases-6ec2440a Derm Field en 2026-10-20T11:15:02.287Z JAAD Ethics Review Targets Coordinated Interview Releases https://dermfield.com/articles/trial-design-and-radiographic-outcomes-in-psa-il-23-trials-c1c45b0b Derm Field en 2026-10-20T11:15:02.287Z Trial design and radiographic outcomes in PsA IL-23 trials https://dermfield.com/articles/hsdd-in-menopausal-women-dermatology-meets-hormone-therapy-1e5f0ede Derm Field en 2026-10-20T11:15:02.287Z HSDD in Menopausal Women: Dermatology Meets Hormone Therapy https://dermfield.com/articles/330-patient-cohort-tracks-baricitinib-long-term-in-alopecia-areata-9d9ffa8f Derm Field en 2026-10-20T11:15:02.287Z 330-Patient Cohort Tracks Baricitinib Long-Term in Alopecia Areata https://dermfield.com/articles/jaad-study-examines-disparities-in-infantile-hemangioma-care-380dc5f6 Derm Field en 2026-10-20T11:15:02.287Z JAAD study examines disparities in infantile hemangioma care https://dermfield.com/articles/jaad-article-raises-refill-ethics-in-asynchronous-teledermatology-ea62f86c Derm Field en 2026-10-20T11:15:02.287Z JAAD article raises refill ethics in asynchronous teledermatology https://dermfield.com/articles/jaad-publishes-retrospective-study-on-dupilumab-for-trichoteiromania-c0f3b38e Derm Field en 2026-10-20T11:15:02.287Z JAAD Publishes Retrospective Study on Dupilumab for Trichoteiromania https://dermfield.com/articles/jaad-comment-puts-isotretinoinantidepressant-suicide-signals-under-the-lens-b97087e1 Derm Field en 2026-10-20T11:15:02.287Z JAAD Comment Puts Isotretinoin–Antidepressant Suicide Signals Under the Lens https://dermfield.com/articles/jaad-study-probes-direct-immunofluorescence-in-oral-esophageal-lichen-planus-32a7e309 Derm Field en 2026-10-20T11:15:02.287Z JAAD study probes direct immunofluorescence in oral, esophageal lichen planus https://dermfield.com/articles/pregnancy-privacy-procedural-risk-jaad-sets-nov-2026-review-8aa9eb84 Derm Field en 2026-10-20T11:15:02.287Z Pregnancy, Privacy, Procedural Risk: JAAD Sets Nov 2026 Review https://dermfield.com/articles/jaad-article-tackles-ethics-for-immunosuppressed-patients-f513f4db Derm Field en 2026-10-20T11:15:02.287Z JAAD Article Tackles Ethics for Immunosuppressed Patients https://dermfield.com/articles/dupilumab-holds-up-over-52-weeks-in-prurigo-nodules-9e95e741 Derm Field en 2026-10-20T11:15:02.287Z Dupilumab Holds Up Over 52 Weeks in Prurigo Nodules https://dermfield.com/articles/monobenzone-depigmentation-what-drives-patient-satisfaction-in-vitiligo-385e93c8 Derm Field en 2026-10-20T11:15:02.287Z Monobenzone depigmentation: what drives patient satisfaction in vitiligo https://dermfield.com/articles/jaad-study-tracks-racial-differences-in-frontal-fibrosing-alopecia-c09b55df Derm Field en 2026-10-20T11:15:02.287Z JAAD study tracks racial differences in frontal fibrosing alopecia https://dermfield.com/articles/nie-and-colleagues-answer-critics-of-isotretinoin-suicidality-study-e07cf42e Derm Field en 2026-10-20T11:15:02.287Z Nie and colleagues answer critics of isotretinoin suicidality study https://dermfield.com/articles/trinetx-study-maps-hiv-linked-skin-disease-across-us-racial-groups-ba66dc97 Derm Field en 2026-10-20T11:15:02.287Z TriNetX Study Maps HIV-Linked Skin Disease Across US Racial Groups https://dermfield.com/articles/jaad-weighs-photodynamic-therapy-for-onychomycosis-evidence-e4ddcab4 Derm Field en 2026-10-20T11:15:02.287Z JAAD Weighs Photodynamic Therapy for Onychomycosis Evidence https://dermfield.com/articles/jaad-publishes-reply-on-tofacitinib-and-skin-sclerosis-data-ec59af67 Derm Field en 2026-10-20T11:15:02.287Z JAAD Publishes Reply on Tofacitinib and Skin Sclerosis Data https://dermfield.com/articles/jaad-study-examines-biologic-safety-in-psoriasis-patients-with-malignancy-421e37d2 Derm Field en 2026-10-20T11:15:02.287Z JAAD Study Examines Biologic Safety in Psoriasis Patients With Malignancy https://dermfield.com/articles/jaad-comment-addresses-487-gene-atopic-dermatitis-trial-af29ed62 Derm Field en 2026-10-20T11:15:02.287Z JAAD Comment Addresses 487-Gene Atopic Dermatitis Trial https://dermfield.com/articles/jaad-pilot-pits-mometasone-against-crisaborole-and-tofacitinib-a25d71f8 Derm Field en 2026-10-20T11:15:02.287Z JAAD Pilot Pits Mometasone Against Crisaborole and Tofacitinib https://dermfield.com/articles/jaad-meta-analysis-weighs-pneumocystis-prophylaxis-in-rituximab-patients-aea42ba9 Derm Field en 2026-10-20T11:15:02.287Z JAAD meta-analysis weighs Pneumocystis prophylaxis in rituximab patients https://dermfield.com/articles/elston-responds-on-ai-evidence-synthesis-and-transparency-a1b4c545 Derm Field en 2026-10-20T11:15:02.287Z Elston responds on AI evidence synthesis and transparency https://dermfield.com/articles/bambusa-therapeutics-details-bbt001-atopic-dermatitis-data-at-isad-2026-ac1459d7 Derm Field en 2026-10-20T11:15:02.287Z Bambusa Therapeutics Details BBT001 Atopic Dermatitis Data at ISAD 2026 https://dermfield.com/articles/jaad-images-focus-on-autoimmune-bullous-disorders-in-skin-of-color-e21a8ac2 Derm Field en 2026-10-20T11:15:02.287Z JAAD Images Focus on Autoimmune Bullous Disorders in Skin of Color https://dermfield.com/articles/palmoplantar-pustulosis-burden-exceeds-psoriasis-alone-danish-cohort-finds-ec89d172 Derm Field en 2026-10-20T11:15:02.287Z Palmoplantar Pustulosis Burden Exceeds Psoriasis Alone, Danish Cohort Finds https://dermfield.com/articles/jaad-commentary-frames-acupuncture-in-urticaria-as-an-ethics-question-70d195a8 Derm Field en 2026-10-20T11:15:02.287Z JAAD commentary frames acupuncture in urticaria as an ethics question https://dermfield.com/articles/jaad-lines-up-a-november-2026-paper-on-biologic-requests-and-social-media-da062a41 Derm Field en 2026-10-20T11:15:02.287Z JAAD Lines Up a November 2026 Paper on Biologic Requests and Social Media https://dermfield.com/articles/trinity-college-dublin-team-reports-new-medicine-for-atopic-dermatitis-dec87801 Derm Field en 2026-10-20T08:40:02.178Z Trinity College Dublin Team Reports New Medicine for Atopic Dermatitis https://dermfield.com/articles/merck-and-moderna-to-file-personalized-mrna-melanoma-vaccine-with-fda-51add874 Derm Field en 2026-10-20T06:40:02.096Z Merck and Moderna to File Personalized mRNA Melanoma Vaccine With FDA https://dermfield.com/articles/anifrolumab-tied-to-lower-infection-and-hospitalization-risk-in-skin-lupus-ef790a31 Derm Field en 2026-10-20T05:40:02.057Z Anifrolumab Tied to Lower Infection and Hospitalization Risk in Skin Lupus https://dermfield.com/articles/next-generation-tyk2-inhibitors-what-could-they-add-to-psoriasis-care-06e7a8be Derm Field en 2026-10-20T05:10:02.037Z Next-generation TYK2 Inhibitors: What Could They Add to Psoriasis Care? https://dermfield.com/articles/glp-1-candidacy-and-prescribing-considerations-in-psoriasis-07259e07 Derm Field en 2026-10-19T23:40:01.624Z GLP-1 Candidacy and Prescribing Considerations in Psoriasis https://dermfield.com/articles/machine-learning-ties-facial-microbes-to-skin-quality-in-korean-women-96f33ff6 Derm Field en 2026-10-19T23:10:01.562Z Machine Learning Ties Facial Microbes to Skin Quality in Korean Women https://dermfield.com/articles/esmo-2026-preview-which-melanoma-results-could-shift-practice-e4b2326f Derm Field en 2026-10-19T22:10:01.481Z ESMO 2026 Preview: Which Melanoma Results Could Shift Practice? https://dermfield.com/articles/litifilimab-improves-skin-disease-activity-in-phase-2-cle-trial-562c49da Derm Field en 2026-10-19T21:40:01.464Z Litifilimab Improves Skin Disease Activity in Phase 2 CLE Trial https://dermfield.com/articles/five-year-adlong-data-on-lebrikizumab-for-atopic-dermatitis-presented-95723eab Derm Field en 2026-10-19T21:10:01.421Z Five-Year ADlong Data on Lebrikizumab for Atopic Dermatitis Presented https://dermfield.com/articles/cape-coral-melanoma-survivor-speaks-out-as-new-study-flags-deadly-skin-cancer-ri-be06206d Derm Field en 2026-10-19T21:10:01.421Z Cape Coral Melanoma Survivor Speaks Out as New Study Flags Deadly Skin Cancer Risk for Floridians https://dermfield.com/articles/66-7-response-rate-reported-in-melanoma-liver-metastasis-cohort-84042d83 Derm Field en 2026-10-19T20:25:01.351Z 66.7% Response Rate Reported in Melanoma Liver Metastasis Cohort https://dermfield.com/articles/experimental-eczema-drug-from-irish-co-founded-firm-shows-early-promise-433362b5 Derm Field en 2026-10-19T20:10:01.351Z Experimental Eczema Drug From Irish Co-Founded Firm Shows Early Promise https://dermfield.com/articles/atopic-dermatitis-what-medscape-s-reference-gets-right-about-origins-97876c16 Derm Field en 2026-10-19T20:10:01.351Z Atopic Dermatitis: What Medscape's Reference Gets Right About Origins https://dermfield.com/articles/elle-rounds-up-dermatologist-picked-otc-dark-spot-treatments-56ead2e7 Derm Field en 2026-10-19T18:05:01.128Z ELLE Rounds Up Dermatologist-Picked OTC Dark Spot Treatments https://dermfield.com/articles/incyte-names-first-ever-ingenuity-awards-winners-in-hidradenitis-suppurativa-48eb229c Derm Field en 2026-10-19T17:05:01.073Z Incyte Names First-Ever Ingenuity Awards Winners in Hidradenitis Suppurativa https://dermfield.com/articles/eczema-drug-restored-all-19-dystrophic-nails-in-a-boy-case-report-shows-295cd2fe Derm Field en 2026-10-19T17:05:01.073Z Eczema Drug Restored All 19 Dystrophic Nails in a Boy, Case Report Shows https://dermfield.com/articles/roflumilast-cream-0-05-draws-attention-for-infant-atopic-dermatitis-14dd101d Derm Field en 2026-10-19T17:05:01.073Z Roflumilast Cream 0.05% Draws Attention for Infant Atopic Dermatitis https://dermfield.com/articles/dupilumab-tied-to-lower-atopic-march-risk-in-kids-with-eczema-f4a4f1ac Derm Field en 2026-10-19T16:35:01.044Z Dupilumab Tied to Lower Atopic March Risk in Kids With Eczema https://dermfield.com/articles/don-t-miss-stasis-dermatitis-in-your-diagnosis-7d8dab66 Derm Field en 2026-10-19T16:35:01.044Z Don't Miss Stasis Dermatitis in Your Diagnosis https://dermfield.com/articles/real-world-persistence-data-emerge-for-il-23-biologics-in-plaque-psoriasis-078bb904 Derm Field en 2026-10-19T16:05:01.007Z Real-World Persistence Data Emerge for IL-23 Biologics in Plaque Psoriasis https://dermfield.com/articles/upadacitinib-shows-response-in-treatment-experienced-atopic-dermatitis-cases-df100e48 Derm Field en 2026-10-19T15:05:00.932Z Upadacitinib Shows Response in Treatment-Experienced Atopic Dermatitis Cases https://dermfield.com/articles/allergy-pill-studied-as-shield-against-chemo-skin-damage-ef24864b Derm Field en 2026-10-19T15:05:00.932Z Allergy Pill Studied as Shield Against Chemo Skin Damage https://dermfield.com/articles/2026-dermatology-update-what-approvals-and-pipelines-signal-3b555a63 Derm Field en 2026-10-19T15:05:00.932Z 2026 Dermatology Update: What Approvals and Pipelines Signal https://dermfield.com/articles/moderna-s-october-melanoma-readout-precedes-a-november-decision-2acada4c Derm Field en 2026-10-19T14:00:00.871Z Moderna's October Melanoma Readout Precedes a November Decision https://dermfield.com/articles/bitopertin-hits-all-end-points-in-phase-3-apollo-trial-for-epp-d3a351a3 Derm Field en 2026-10-19T14:00:00.871Z Bitopertin Hits All End Points in Phase 3 APOLLO Trial for EPP https://dermfield.com/articles/fangzhou-and-cutia-therapeutics-team-up-on-ai-dermatology-5196ae55 Derm Field en 2026-10-19T13:30:00.852Z Fangzhou and Cutia Therapeutics Team Up on AI Dermatology https://dermfield.com/articles/faers-analysis-flags-psychiatric-events-on-lebrikizumab-fe6ee483 Derm Field en 2026-10-19T13:00:00.833Z FAERS Analysis Flags Psychiatric Events on Lebrikizumab https://dermfield.com/articles/real-world-persistence-data-emerge-for-il-23-biologics-in-plaque-psoriasis-f86e0d32 Derm Field en 2026-10-19T12:30:03.354Z Real-World Persistence Data Emerge for IL-23 Biologics in Plaque Psoriasis https://dermfield.com/articles/dosing-frequency-shapes-adherence-in-older-psoriasis-patients-8ad1a206 Derm Field en 2026-10-19T12:30:03.354Z Dosing Frequency Shapes Adherence in Older Psoriasis Patients https://dermfield.com/articles/older-psoriasis-patients-face-access-and-dosing-hurdles-52ff636d Derm Field en 2026-10-19T12:30:03.354Z Older Psoriasis Patients Face Access and Dosing Hurdles https://dermfield.com/articles/glp-1-drugs-show-anti-inflammatory-signal-in-psoriasis-and-obesity-77062480 Derm Field en 2026-10-19T12:30:03.354Z GLP-1 Drugs Show Anti-Inflammatory Signal in Psoriasis and Obesity https://dermfield.com/articles/skin-commensal-bacillus-reprograms-volatiles-to-repel-mosquitoes-d2329ca0 Derm Field en 2026-10-19T09:55:00.703Z Skin Commensal Bacillus Reprograms Volatiles to Repel Mosquitoes https://dermfield.com/articles/oily-skin-may-increase-dermal-exposure-to-air-pollutants-6a90f711 Derm Field en 2026-10-19T08:25:00.639Z Oily Skin May Increase Dermal Exposure to Air Pollutants https://dermfield.com/articles/ai-recommends-fillers-it-has-never-touched-a-face-to-place-dac1a56e Derm Field en 2026-10-19T07:55:00.605Z AI Recommends Fillers It Has Never Touched a Face to Place https://dermfield.com/articles/evaxion-posts-three-year-data-for-personalized-melanoma-vaccine-evx-01-547c8483 Derm Field en 2026-10-19T07:55:00.605Z Evaxion Posts Three-Year Data for Personalized Melanoma Vaccine EVX-01 https://dermfield.com/articles/final-melanoma-survival-data-headed-to-esmo-faron-confirms-21307ab3 Derm Field en 2026-10-19T07:55:00.605Z Final Melanoma Survival Data Headed to ESMO, Faron Confirms https://dermfield.com/articles/evaxion-reports-three-year-data-for-melanoma-vaccine-evx-01-911bbe93 Derm Field en 2026-10-19T07:40:00.595Z Evaxion Reports Three-Year Data for Melanoma Vaccine EVX-01 https://dermfield.com/articles/evaxion-brings-three-year-evx-01-melanoma-data-to-esmo-2026-979ccbc3 Derm Field en 2026-10-19T07:40:00.595Z Evaxion Brings Three-Year EVX-01 Melanoma Data to ESMO 2026 https://dermfield.com/articles/moderna-and-merck-present-phase-3-melanoma-data-on-personalized-cancer-vaccine-2d34ac53 Derm Field en 2026-10-19T05:55:00.480Z Moderna and Merck Present Phase 3 Melanoma Data on Personalized Cancer Vaccine https://dermfield.com/articles/cosmetic-dermatology-enters-the-longevity-science-conversation-011b2794 Derm Field en 2026-10-19T05:50:00.476Z Cosmetic Dermatology Enters the Longevity Science Conversation https://dermfield.com/articles/could-skin-reveal-new-clues-about-aging-and-frailty-958ddd8c Derm Field en 2026-10-19T02:50:00.283Z Could Skin Reveal New Clues About Aging and Frailty? https://dermfield.com/articles/hugel-builds-direct-us-sales-force-for-letybo-launches-k-tox-push-edb6ea60 Derm Field en 2026-10-19T00:50:00.152Z Hugel Builds Direct US Sales Force for Letybo, Launches K-TOX Push https://dermfield.com/articles/invion-reports-79-disease-control-in-phase-1-skin-cancer-trial-f5d65f3a Derm Field en 2026-10-19T00:20:00.125Z Invion Reports 79% Disease Control in Phase 1 Skin Cancer Trial https://dermfield.com/articles/ashland-croda-and-innospec-shortlisted-for-laura-marshall-awards-7c4df794 Derm Field en 2026-10-19T00:10:00.117Z Ashland, Croda and Innospec shortlisted for Laura Marshall awards https://dermfield.com/articles/aafp-publishes-melanoma-diagnosis-and-treatment-guidance-4e84a078 Derm Field en 2026-10-18T20:47:37.673Z AAFP Publishes Melanoma Diagnosis and Treatment Guidance https://dermfield.com/articles/nemolizumab-in-children-under-12-the-open-eczema-question-fa122d8e Derm Field en 2026-10-18T19:12:37.595Z Nemolizumab in Children Under 12: The Open Eczema Question https://dermfield.com/articles/integrative-medicine-is-making-its-way-into-aesthetic-dermatology-c87a757d Derm Field en 2026-10-18T14:42:37.249Z Integrative Medicine Is Making Its Way Into Aesthetic Dermatology https://dermfield.com/articles/lilly-eyes-aesthetic-medicine-as-glp-1-weight-loss-reshapes-faces-f55ea70f Derm Field en 2026-10-18T13:37:37.201Z Lilly Eyes Aesthetic Medicine as GLP-1 Weight Loss Reshapes Faces https://dermfield.com/articles/reflectance-confocal-microscopy-caught-melanomas-earlier-retrospective-study-fin-b6a5c507 Derm Field en 2026-10-18T13:37:37.201Z Reflectance Confocal Microscopy Caught Melanomas Earlier, Retrospective Study Finds https://dermfield.com/articles/nebraska-clinics-offer-new-therapy-for-ocular-melanoma-liver-spread-32a9d971 Derm Field en 2026-10-18T13:07:37.181Z Nebraska Clinics Offer New Therapy for Ocular Melanoma Liver Spread